Advertisement

Das Restless-legs-Syndrom (RLS)

  • J. Winkelmann
  • T.-C. Wetter
  • C. Trenkwalder
Chapter
  • 15 Downloads

Zusammenfassung

Das Restless-legs-Syndrom (RLS) ist eine eigenständige neurologische Erkrankung, die durch unangenehme Mißempfindungen in den Beinen, seltener auch in den Armen, charakterisiert ist. Mit diesen Sensationen ist ein starker innerer Drang verbunden, die jeweilige Extremität zu bewegen, so daß die Betroffenen gezwungen sind, aufzustehen und umherzugehen. Durch die Bewegung kommt es zu einer Besserung der Beschwerden. Die Symptome treten typischerweise nur in Ruhepositionen auf und unterliegen einer zirkadianen Rhythmik mit einem Schwerpunkt in den Abendstunden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Akpinar S (1982) Treatment of restless legs syndrome with levodopa plus benserazide (letter). Arch Neurol: 39: 739PubMedCrossRefGoogle Scholar
  2. 2.
    Ancoli-Israel A, Seifert AR, Lemon M (1986) Thermal biofeedback and periodic movements in sleep: Patients’ subjective report and a case study. Biofeedback Self Regul 86: 177–188CrossRefGoogle Scholar
  3. 3.
    American Sleep Disorders Association (1990) Periodic limb movements disorder and restless legs syndrome. The International Classification of Sleep Disorders Diagnostic and Coding Manual. Allen, Lawrence, Kansas, pp 65 – 71Google Scholar
  4. 4.
    Ausserwinkler M, Schmidt P (1989) Erfolgreiche Behandlung des “restless legs” Syndroms bei chronischer Niereninsuffizienz mit Clonidin. Schweiz Med Wochenschr 119 :184 – 186PubMedGoogle Scholar
  5. 5.
    Avi Sadeh A, Hauri J, Kipke DF, Lavie P (1995) The role of actigraphy in the evaluation of sleep disorders. Sleep 18: 288–302Google Scholar
  6. 6.
    Boghen D, Peyronnard JM (1976) Myoclonus in familial restless legs syndrome. Arch Neurol 33: 368 – 370PubMedCrossRefGoogle Scholar
  7. 7.
    Bonnet MH, Arand DL (1991) Chronic use of triazolam in patients with periodic leg movements, fragmented sleep and daytime sleepiness. Aging (Milano) 3: 313–324Google Scholar
  8. 8.
    Brodeur C, Montplaisir J, Godbout R, Marinier R (1988) Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology 38 :1845 – 1848PubMedCrossRefGoogle Scholar
  9. 9.
    Bucher SF, Seelos K, Reiser M et al. (1997) Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol 41: 639 – 645PubMedCrossRefGoogle Scholar
  10. 10.
    Coleman R (1982) Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In: Guilleminault C (ed) Sleep and waking: indications and techniques. Addison-Wesley, Menlo Park/CA, pp 265 – 295Google Scholar
  11. 11.
    Collado-Seidel V, Kohnen R, Samtleben W et al. (1998) Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis 31: 324 – 328PubMedCrossRefGoogle Scholar
  12. 12.
    Earley C, Allen R (1997) Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep 19:801–810Google Scholar
  13. 13.
    Ekbom KA (1945) Restless legs syndrome. Acta Med Scand 158 (Suppl): 4–122Google Scholar
  14. 14.
    Ekbom KA (1969) Restless legs syndrome. Neurology 10: 868 – 873CrossRefGoogle Scholar
  15. 15.
    Ekbom KA (1970) Restless legs. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology. North Holland, Amsterdam New York, pp 311–320Google Scholar
  16. 16.
    Goodman JD, Brodie C, Ayida GA (1988) Restless leg syndrome in pregnancy. Br Med J 297:1101–1102CrossRefGoogle Scholar
  17. 17.
    Guilleminault C, Raynal D, Weitzman ED, Dement WC (1975) Sleep-related periodic myoclonus in patients complaining of insomnia. Trans Am Neurol Assoc 100: 19–22PubMedGoogle Scholar
  18. 18.
    Handwerker J Jr, Palmer RF (1985) Clonidine in the treatment of “restless leg” syndrome (letter). N Engl J Med 313: 1228 – 1229PubMedCrossRefGoogle Scholar
  19. 19.
    Hemmer B, Riemann D, Glocker FX et al. (1995) Restless-legs-syndrome after borrelia induced myelitis. Mov Disord 10: 521–526PubMedCrossRefGoogle Scholar
  20. 20.
    Hening WA, Walters A, Kavey N et al. (1986) Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioids. Neurology 36: 1363 – 1366PubMedCrossRefGoogle Scholar
  21. 21.
    Johnson W, Walters A, Lehner T et al. (1992) Affecteds only linkage analysis of autosomal dominant restless legs syndrome. Sleep Res 21: 214Google Scholar
  22. 22.
    Kaplan PW, Allen RP, Buchholz DW, Walters JK (1993) A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep 16: 717–723PubMedGoogle Scholar
  23. 23a.
    Kazenwadel J, Pollmächer T, Trenkwalder C et al. (1995) New actigraphic assessment method for periodic leg movements (PLM). Sleep 18: 689–697PubMedGoogle Scholar
  24. 23b.
    Kovačevid-Ristanovid R, Cartwright RD, Lloyd S (1991) Nonpharmacologic treatment of periodic leg movements in sleep. Arch Phys Med Rehabil 72: 385 – 389Google Scholar
  25. 24.
    Lang AE (1987) Restless legs syndrome and Parkinson’s disease: insights into pathophysiology. Clin Neuropharmacol 10: 476 – 478PubMedCrossRefGoogle Scholar
  26. 25.
    Larsen S, Telstad W, Sorensen O et al. (1985) Carbamazepine therapy in restless legs. Acta Med Scand 218: 223 – 227PubMedCrossRefGoogle Scholar
  27. 26.
    Lugaresi E, Cirignotta F, Coccagna G, Montagna P (1986) Nocturnal myoclonus and restless legs syndrome. Adv Neurol 43: 295–307PubMedGoogle Scholar
  28. 27.
    Matthews WB (1979) Treatment of restless legs syndrome with clonazepam (letter). Br Med J 1:751PubMedCrossRefGoogle Scholar
  29. 28.
    Mellick GA, Mellick LB (1995) Successful treatment of restless legs syndrome with gabapentin (Neurontin). Neurology 45 (Suppl 4): 446 SGoogle Scholar
  30. 29.
    Montagna P, Coccagna G, Cirignotta F, Lugaresi E (1983) Familial restless legs syndrome: long-term follow-up. In: Guilleminault C, Lugaresi E (eds) Sleep/wake disorders: natural history, epidemiology, and long-term evolution. Raven, New York, pp 231 – 235Google Scholar
  31. 30.
    Montagna P, Sassoli de Bianchi L, Zucconi M et al. (1984) Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand 69: 428 – 430PubMedCrossRefGoogle Scholar
  32. 31.
    Montplaisir J, Lapierre O, Warnes H, Pelletier G (1992) The treatment of the restless leg syndrome with or without periodic leg movements in sleep. Sleep 15: 391–395PubMedGoogle Scholar
  33. 32.
    Mosko SS, Nudleman KL (1986) Somatosensory and brainstem auditory evoked responses in sleep-related periodic leg movements. Sleep 9: 399–404PubMedGoogle Scholar
  34. 33.
    Mussio Fournier JC, Rawak F (1940) Familiäres Auftreten vom Pruritus, Urtikaria und parästhetischer Hyperkinese der unteren Extremitäten. Confin Neurol Basel 3 : 110 – 114CrossRefGoogle Scholar
  35. 34.
    O’Keeffe ST, Gavin K, Lavan JN (1994) Iron status and restless legs syndrome in the elderly. Age Ageing 23: 200 – 203PubMedCrossRefGoogle Scholar
  36. 35.
    Ondo W, Jankovic J (1996) Restless legs syndrome: Clinicoetiologic correlates. Neurology 47 :1435–1441PubMedCrossRefGoogle Scholar
  37. 36.
    Picchietti DL, Walters AS (1996) Restless legs syndrome and periodic limb movement disorder in children and adolescents. Child Adolescent Psychiatr Clin North Am 5: 729 – 740Google Scholar
  38. 37.
    Pollmächer T, Schulz H (1993) Periodic leg movements (PLM): their relationship to sleep stages. Sleep 16: 572 – 577PubMedGoogle Scholar
  39. 38.
    Read D, Feest T, Nassim M (1981) Clonazepam: effective treatment for restless leg syndrome in uremia. Br Med J 283: 885 – 886CrossRefGoogle Scholar
  40. 39.
    Reynolds G, Blake DR, Pall HS, Williams A (1986) Restless leg syndrome and rheumatoid arthritis. Br Med J 292: 659 – 660CrossRefGoogle Scholar
  41. 40.
    Sachdev P (1995) Akathisia and restless legs. Cambridge Univ Press, New YorkCrossRefGoogle Scholar
  42. 41.
    Scharf MB, Brown L, Hirschowitz J (1986) Possible efficacy of alprazolam in restless leg syndrome. Hillside J Clin Psychiatr 8: 214 – 223Google Scholar
  43. 42.
    Smith R (1985) Relationship of periodic movements in sleep (nocturnal myoclonus) and the Babinski sign. Sleep 8: 239 – 243PubMedGoogle Scholar
  44. 43.
    Trenkwalder C, Bucher SF, Oertel WH et al. (1993) Bereitschaftspotential in idiopathic and symptomatic restless legs syndrome. Electroencephalogr Clin Neurophysiol 89: 95–103PubMedCrossRefGoogle Scholar
  45. 44.
    Trenkwalder C, Stiasny K, Pollmächer T et al. (1995) L-DOPA therapy of uremic and idiopathic restless legs syndrome: a double-blind crossover trial. Sleep 18: 681–688PubMedGoogle Scholar
  46. 45.
    Trenkwalder C, Collado-Seidel V, Gasser T, Oertel WH (1996) Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome. Mov Disord 11: 389 – 394PubMedCrossRefGoogle Scholar
  47. 46.
    Trenkwalder C, Walters AS, Henning WA (1998) Circadian rhythm of periodic limb movements and sensory symptoms in the idiopathic restless legs syndrome. Mov Disord (in press)Google Scholar
  48. 47.
    Trenkwalder C (1998) Restless legs Syndrom, Klinik, Differentialdiagnose, Neurophysiologie, Therapie. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  49. 48.
    Vahedi H, Kuchle M, Trenkwalder C, Krenz CJ (1994) Peridurale Morphiumanwendung bei Restless-legs-Status. Anästhesiol Intensivmed Notfallmed Schmerzther 29 :368–370PubMedCrossRefGoogle Scholar
  50. 49.
    Wagner ML, Walters AS, Coleman R (1994) A double-blind study of clonidine in the restless legs syndrome. Sleep 19: 52 – 58Google Scholar
  51. 50.
    Walters AS, Hening W (1987) Clinical presentation and neuropharmacology of restless legs syndrome. Clin Neuropharmacol 10: 225 – 237PubMedCrossRefGoogle Scholar
  52. 51.
    Walters AS, Hening WA, Kavey N et al. (1988) A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 24:455–458PubMedCrossRefGoogle Scholar
  53. 52.
    Walters AS, Picchietti D, Hening W, Lazzarini A (1990) Variable expressivity in familial restless legs syndrome. Arch Neurol 47 :1219–1220PubMedCrossRefGoogle Scholar
  54. 53.
    Walters A, Johnson W, Hening W et al. (1992) Preliminary evidence for possible genetic linkage in the restless legs syndrome. J Sleep Res 1 (Suppl 1): 248Google Scholar
  55. 54.
    Walters AS, Wagner ML, Hening WA et al. (1993) Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone vs. placebo. Sleep 16:327–332PubMedGoogle Scholar
  56. 55.
    Walters A, Hickey K, Maltzman J et al. (1996) A questionnaire study of 138 patients with restless legs syndrome: the “Night-Walkers” survey. Neurology 46: 92–95PubMedCrossRefGoogle Scholar
  57. 56.
    Walters AS, Wagner M, Hening WA (1996) Periodic limb movements as the initial manifestation of restless legs syndrome triggered by lumbosacral radiculopathy (letter). Sleep 19: 825 – 826PubMedGoogle Scholar
  58. 57.
    Wetter TC, Stiasny K, Winkelmann J et al. (1998) A polysomnographic, controlled study of pergolide in the treatment of restless legs syndrome. Neurology (Suppl) (in press)Google Scholar
  59. 58.
    Willis T (1685) The London practice of physick. Bassett & Crooke, London (404 pp)Google Scholar
  60. 59.
    Winkelmann J (1997) Charakteristika des hereditären Restless legs syndrom in einer Population von 300 Patienten. Max-Planck Institut für Psychiatrie, Luwig-MaximiliansUniv, München (Dissertation)Google Scholar
  61. 60.
    Winkelmann J, Wetter TC, Stiasny K et al. (1998) Treatment of restless legs syndrome with pergolide — an open clinical trial. Mov Disord 13: 566–569PubMedCrossRefGoogle Scholar
  62. 61.
    Yasuda T, Nishimura A, Katsuki Y, Tsuji Y (1991) Restless legs syndrome treated successfully by kidney transplantation — A case report. Clin Transpl 138 :138Google Scholar
  63. 62.
    Zucconi M, Coccagna G, Petronelli R et al. (1991) Nocturnal myoclonus in restless legs syndrome: effect of carbamazepine treatment. Funct Neurol 4: 263 – 271Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • J. Winkelmann
  • T.-C. Wetter
  • C. Trenkwalder

There are no affiliations available

Personalised recommendations